Skip to content

Ondas, Inc. ONDS Royalty Payments Percentage

Royalty Payments Percentage at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$11.69M-9.3%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
4%
Baxter International logo
Baxter InternationalBAX
3%
Jaguar Uranium
 logo
Jaguar Uranium JAGU
1%
Hasbro logo
HasbroHAS
$77.7M+36.3%
Alkermes logo
AlkermesALKS
3.8%0.0pp

Other financials

Income statement

See full
Revenue$50.1M+1,080%
Gross profit$24.7M+1,557%
Operating income-$42.7M-314%
Net income$362.8M+2,666%
EPS (diluted)$0.56+473%

Balance sheet

See full
Cash & equivalents$1.0B+3,989%
Total debt$12.5M-64.8%
Total equity$1.1B+4,018%
Total assets$2.4B+2,232%

Cash flow

See full
Operating cash flow-$51.3M-670%
CapEx$1.3M+679%
Free cash flow-$52.6M-671%

Valuation

See full
Market cap$4.82B+3,648%

Profitability

See full
Gross margin44.8%+24.2pp
Operating margin-93.9%-39.2pp
Net margin253.3%+158pp
FCF margin-89.6%-37.2pp

Returns & leverage

See full
Return on equity44.5%+25.0pp
Debt / equity-1.4×
Current ratio10.9×+10.1×

Where this comes from

Reported directly by Ondas, Inc. in its filing.

Tagged under the XBRL concept onds:RoyaltyPaymentsPercentage.

The official record: Ondas, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ondas, Inc. 's royalty payments percentage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ondas, Inc. 's royalty payments percentage?
Ondas, Inc. (ONDS) reported royalty payments percentage of 3% in Q1 2026.
How has Ondas, Inc. 's royalty payments percentage changed year-over-year?
Ondas, Inc. 's royalty payments percentage decreased by 0.0% year-over-year, from 3% to 3%.
What does royalty payments percentage mean?
The proportion of revenue or specific product sales paid to third parties as royalties for the use of intellectual property or licensed technology. This metric measures the cost burden associated with external technology dependencies relative to total sales.